• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchKazia Therapeutics
    Picture of Kazia Therapeutics logo

    KZIA — Kazia Therapeutics News Story

    $8.070.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    • Market Cap
      $0.07m
    • Enterprise Value
      -$38.66m
    • Revenue
      AU$0.11m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • KZIA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    KZIA Dividends
    All News

    NASDAQ RESUMED

    Picture of Kazia Therapeutics logoKazia Therapeutics
    25/09/2019 20:11
    NASDAQ RESUMED  KZIA.O
    

    Recent news on Kazia Therapeutics

    See all news
    • U.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech

      28/08/2026 18:40
    • U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics

      28/08/2026 17:04
    • Kazia drops on $40 mln equity offering to fund breast cancer drug

      28/08/2026 14:01
    • Kazia slides after breast cancer drug update, equity offering launch

      27/08/2026 22:19
    • Brief: Kazia Therapeutics Limited Announces Proposed Public Offering

      27/08/2026 21:35

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.